PV Loop & Coarctation Study

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status

Enrolling

Conditions

Coarctation of Aorta

Treatments

Diagnostic Test: Pressure-volume loop catheter

Study type

Observational

Funder types

Other

Identifiers

NCT05362721
PEDS-2019-27404

Details and patient eligibility

About

Coarctation of the aorta accounts for 4-7% of all congenital heart disease. While stent therapy, when feasible, is the standard of care for coarctation, it may not completely improve the work (and afterload) of the heart due to its effects on the elasticity of the aorta. This study will provide the information needed to understand the effects of current management on the cardiac mechanics and work.

Enrollment

20 estimated patients

Sex

All

Ages

6+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children 6 years of age and older and adults of all races and both sexes referred for elective cardiac catheterization and stent therapy for coarctation
  • Those who provide informed consent for study participant.

Exclusion criteria

  • Children who undergo other interventions in addition to the coarctation
  • Children with single ventricle physiology.
  • Renal impairment
  • Participant unwilling to sign a consent form.

Trial design

20 participants in 1 patient group

Pressure-volume loop catheter
Treatment:
Diagnostic Test: Pressure-volume loop catheter

Trial contacts and locations

7

Loading...

Central trial contact

Brittany Faanes

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems